VAR insider filings

VARIAN MEDICAL SYSTEMS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-04-16. Screen VAR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VAR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — VARIAN MEDICAL SYSTEMS INC

FiledFormInsiderReported transactionsSource
2021-04-164O'Reilly Kevin — SVP, President of Oncology SysDisposition to issuer (D): 1,556 · Disposition to issuer (D): 2,587 (derivative) @ $112.82 · Disposition to issuer (D): 6,859 (derivative) @ $131.77 · Disposition to issuer (D): 7,846 (derivative) @ $146.91 · Disposition to issuer (D): 506 (derivative) · Disposition to issuer (D): 1,059 (derivative) · +3 moreEDGAR
2021-04-164Le Beau Michelle — DirectorDisposition to issuer (D): 1,333 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164Ashkenazi Anat — DirectorDisposition to issuer (D): 2,574 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164Toth Christopher A. — SVP and Pres. Oncology SystemsDisposition to issuer (D): 15,418 · Disposition to issuer (D): 633 (derivative) · Disposition to issuer (D): 1,816 (derivative) · Disposition to issuer (D): 6,415 (derivative) · Disposition to issuer (D): 8,437 (derivative)EDGAR
2021-04-164Balser Jeffrey R. — DirectorDisposition to issuer (D): 2,824 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164MOMSEN MAGNUS — SVP, CAO, Corporate ControllerDisposition to issuer (D): 724 · Disposition to issuer (D): 5,819 (derivative) @ $112.82 · Disposition to issuer (D): 3,429 (derivative) @ $131.77 · Disposition to issuer (D): 3,923 (derivative) @ $146.91 · Disposition to issuer (D): 253 (derivative) · Disposition to issuer (D): 530 (derivative) · +3 moreEDGAR
2021-04-164Febbo Phillip G. — DirectorDisposition to issuer (D): 1,699 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164Hutchinson Michael Damon — SVP,Chief Legal Officer, SecyDisposition to issuer (D): 5,589 · Disposition to issuer (D): 7,204 (derivative)EDGAR
2021-04-164DUGAN REGINA E — DirectorDisposition to issuer (D): 12,396 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164KENNEDY KOLLEEN T — Pres. Proton Solutions, CGODisposition to issuer (D): 29,249 · Disposition to issuer (D): 1,630 (derivative) @ $112.82 · Disposition to issuer (D): 6,002 (derivative) @ $131.77 · Disposition to issuer (D): 14,122 (derivative) @ $146.91 · Disposition to issuer (D): 1,063 (derivative) · Disposition to issuer (D): 12,103 (derivative) · +3 moreEDGAR
2021-04-164WILSON DOW R — President and CEO, DirectorGift (G): 46,700 @ $0 · Gift (G): 15,460 @ $0 · Gift (G): 3,398 @ $0 · Disposition to issuer (D): 39,231 · Disposition to issuer (D): 23,577 (derivative) · Disposition to issuer (D): 20,763 (derivative) · +3 moreEDGAR
2021-04-164BUTEL JEAN LUC — DirectorDisposition to issuer (D): 4,048 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164ECKERT R ANDREW — DirectorGift (G): 277 @ $0 · Gift (G): 170 @ $0 · Disposition to issuer (D): 13,826 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164BRUNER JUDY — DirectorDisposition to issuer (D): 6,779 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-04-164ILLINGWORTH DAVID J — DirectorDisposition to issuer (D): 15,369 · Disposition to issuer (D): 1,022 (derivative)EDGAR
2021-03-034Bruff Jesse Michael — SVP Finance, CFOSale (S): 6,499 @ $175.81EDGAR
2021-02-174O'Reilly Kevin — SVP, President of Oncology SysOption exercise (M): 493 · Option exercise (M): 506 · Option exercise (M): 529 · Tax withholding (F): 848 @ $176.15 · Option exercise (M): 493 (derivative) · Option exercise (M): 506 (derivative) · +1 moreEDGAR
2021-02-174Bruff Jesse Michael — SVP Finance, CFOOption exercise (M): 197 · Option exercise (M): 422 · Option exercise (M): 680 · Tax withholding (F): 476 @ $176.15 · Option exercise (M): 197 (derivative) · Option exercise (M): 422 (derivative) · +1 moreEDGAR
2021-02-174Le Beau Michelle — DirectorOption exercise (M): 1,333 · Option exercise (M): 1,333 (derivative)EDGAR
2021-02-174Ashkenazi Anat — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174Toth Christopher A. — SVP and Pres. Oncology SystemsOption exercise (M): 837 · Option exercise (M): 632 · Option exercise (M): 907 · Tax withholding (F): 848 @ $176.15 · Option exercise (M): 837 (derivative) · Option exercise (M): 632 (derivative) · +1 moreEDGAR
2021-02-174Balser Jeffrey R. — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174MOMSEN MAGNUS — SVP, CAO, Corporate ControllerOption exercise (M): 370 · Option exercise (M): 253 · Option exercise (M): 264 · Tax withholding (F): 342 @ $176.15 · Option exercise (M): 370 (derivative) · Option exercise (M): 253 (derivative) · +1 moreEDGAR
2021-02-174Febbo Phillip G. — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174DUGAN REGINA E — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174KENNEDY KOLLEEN T — Pres. Proton Solutions, CGOOption exercise (M): 1,241 · Option exercise (M): 1,062 · Option exercise (M): 953 · Tax withholding (F): 1,118 @ $176.15 · Option exercise (M): 1,241 (derivative) · Option exercise (M): 1,062 (derivative) · +1 moreEDGAR
2021-02-174BUTEL JEAN LUC — DirectorOption exercise (M): 1,225 · Tax withholding (F): 367 @ $176.15 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174ECKERT R ANDREW — DirectorGift (G): 50 @ $0 · Option exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174BRUNER JUDY — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-174ILLINGWORTH DAVID J — DirectorOption exercise (M): 1,225 · Option exercise (M): 1,225 (derivative)EDGAR
2021-02-164Le Beau Michelle — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164Ashkenazi Anat — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164Balser Jeffrey R. — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164Febbo Phillip G. — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164DUGAN REGINA E — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164BUTEL JEAN LUC — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164ECKERT R ANDREW — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164BRUNER JUDY — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2021-02-164ILLINGWORTH DAVID J — DirectorGrant/award (A): 1,022 (derivative) @ $0EDGAR
2020-12-144MOMSEN MAGNUS — SVP, CAO, Corporate ControllerOption exercise (M): 4,473 @ $81.97 · Sale (S): 4,473 @ $174.95 · Option exercise (M): 4,473 (derivative) @ $0EDGAR
2020-12-104WILSON DOW R — President and CEO, DirectorOption exercise (M): 159,198 @ $109.03 · Sale (S): 159,198 @ $174.40 · Gift (G): 16,800 @ $0 · Grant/award (A): 159,198 (derivative) @ $109.03 · Option exercise (M): 159,198 (derivative) @ $0EDGAR
2020-12-094WILSON DOW R — President and CEO, DirectorOption exercise (M): 111,830 @ $81.97 · Sale (S): 82,500 @ $174.35 · Option exercise (M): 75,015 @ $80.40 · Sale (S): 75,015 @ $174.35 · Option exercise (M): 111,830 (derivative) @ $0 · Option exercise (M): 75,015 (derivative) @ $0EDGAR
2020-12-084MOMSEN MAGNUS — SVP, CAO, Corporate ControllerOption exercise (M): 6,064 @ $67.12 · Sale (S): 6,064 @ $174.41 · Option exercise (M): 8,266 @ $80.40 · Sale (S): 8,266 @ $174.51 · Sale (S): 1,032 @ $174.47 · Sale (S): 547 @ $174.47 · +2 moreEDGAR
2020-12-034Bruff Jesse Michael — SVP Finance, CFOOption exercise (M): 3,750 @ $99.26 · Tax withholding (F): 2,936 @ $174.19 · Option exercise (M): 1,035 @ $112.82 · Tax withholding (F): 851 @ $174.19 · Option exercise (M): 5,716 @ $131.77 · Tax withholding (F): 5,014 @ $174.19 · +9 moreEDGAR
2020-12-034Toth Christopher A. — SVP and Pres. Oncology SystemsOption exercise (M): 4,823 @ $80.40 · Tax withholding (F): 3,514 @ $174.19 · Option exercise (M): 8,794 @ $112.82 · Tax withholding (F): 7,232 @ $174.19 · Option exercise (M): 8,573 @ $131.77 · Tax withholding (F): 7,521 @ $174.19 · +9 moreEDGAR
2020-12-034Hutchinson Michael Damon — SVP,Chief Legal Officer, SecyOption exercise (M): 11,014 @ $0 · Tax withholding (F): 5,425 @ $174.19 · Option exercise (M): 11,014 (derivative) @ $0EDGAR
2020-11-254Toth Christopher A. — SVP and Pres. Oncology SystemsGrant/award (A): 1,914 @ $0 · Tax withholding (F): 667 @ $173.50EDGAR
2020-11-254MOMSEN MAGNUS — SVP, CAO, Corporate ControllerGrant/award (A): 844 @ $0 · Tax withholding (F): 297 @ $173.50EDGAR
2020-11-254KENNEDY KOLLEEN T — Pres. Proton Solutions, CGOGrant/award (A): 8,513 @ $0 · Tax withholding (F): 4,225 @ $173.50 · Sale (S): 4,288 @ $174.15EDGAR
2020-11-254WILSON DOW R — President and CEO, DirectorGrant/award (A): 18,952 @ $0 · Tax withholding (F): 9,401 @ $173.50EDGAR

Recent 8-K events — VARIAN MEDICAL SYSTEMS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-04-158-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-04-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2021-03-088-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-03-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-01-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-248-K8.01 — Other EventsEDGAR
2020-10-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2020-10-238-K8.01 — Other EventsEDGAR
2020-10-158-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VAR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs